Changes of pregabalin and gabapentin

by | Apr 2, 2019 | Blog

Decision made by Home Office, which comes into force from 1st of April 2019 that pregabalin and gabapentin is placed in schedule 3 controlled drug under the Misuse of Drugs Regulations 2001. But would be excluded from the requirement to be stored in a safe.

Pharmacists and staff need to be aware of the change and act accordingly. The NPA guidance outlining the changes.

Prescription writing requirements will apply, including:

  • Clearly defined dose
  • Correct formulation
  • Strength, as appropriate
  • Total quantity/dosage units in both words and figures
  • Prescription validity is 28 days
  • strong recommendation that the maximum quantity of all Schedule 3 CDs prescribed should not exceed 30 days

emergency supply cannot be made

Testimonials

Having just completed the very informative API and Clinical Trail course (thank you Shankar) I was reminded of the traps we can fall into whereby we try to keep ourselves in our little boxes. At the MHRA symposium, I have heard several times comments such as:- “no, I’m not doing the GMP day as it’s not relevant to me” or “GDP? Oh, that doesn’t apply to us as we are manufacturers”. I am sure these comments were made well out of the earshot of MHRA personnel and on the face of it see… Read more
API and Clinical Trails Training